Craig has been here since I started following this board
Craig has been here since I started following this board 2018-2019 and he hasn’t changed. He’s just abrasive in his views. I remember one of my first post I wrote something about, Craig take it easy on me if I miss spelled something or misphrased someone. He’s not a short(I don’t believe), he’s just ready to be paid off for his time and willingness not to sell his shares(which are probably plentiful, like everyone else who began investing back then). It’s ok to state your dislikes after holding for that long. We are all waiting to make it to the big time. I don’t believe it’s all Naders fault or all the FDAs, it’s in between. But.... we are so freaking close right now that I almost bought more on Friday. I couldn’t pull the trigger because I have over 35k shares and will not give more $ until something is finished- approval or strong revenue. Once one of those hit, I’ll throw in more cash along with every other private investor and institution. We will be sitting pretty one day soon!! Our company deserves it! Our molecule! People on every continent! Our investors as well! We have carried the weight for years on our short pockets and we never sold no matter what BS big Pharma has put against us. We will win and it will be worth it. Our time is here!! FINALLY!!!!
8
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
TCM Group A/S Reports Major Shareholder Developments In an important corporate announcement, TCM Group A/S has disclosed significant shifts in its shareholder structure. According to updates released under section 30 of the Danish Capital Markets Act, the well-known banking institution, Bank of America Corporation, has altered its position regarding stock holdings and...
Continue Reading
Four Seasons Education Files Annual Report for Fiscal Year 2025 Four Seasons Education (Cayman) Inc. (NYSE: FEDU), a prominent player in the tourism and education sector, is excited to announce the filing of its annual report on Form 20-F with the Securities and Exchange Commission (SEC). This comprehensive report outlines the performance and financial results for the...
Continue Reading
Exploring the Future of Finance: May Edition Highlights In the latest release, FinTech Magazine examines the evolving landscape of financial services, focusing on innovative solutions for businesses and consumers alike. This month's edition features a remarkable collection of stories impacting the world of finance, highlighting industry leaders and their unique...
Continue Reading
Atradius Secures Lloyd's Underwriting Approval Atradius has officially received regulatory approval for its Lloyd's Syndicate 1864, paving the way for enhanced trade credit risk management starting January 1, 2026. This significant achievement follows prior approvals received earlier in the year, confirming Atradius' commitment to providing top-tier solutions for...
Continue Reading
Velera Teams Up with Kinective for Enhanced Financial Solutions In a dynamic move toward enhancing innovation and efficiency in the financial technology sector, Velera has formed a strategic partnership with Kinective. This collaboration aims to accelerate the market introduction of cutting-edge software products specifically designed for credit unions, providing the...
Continue Reading
